NKTR
$39.22+7.04%
Nektar TherapeuticsStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.004% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
Nektar Therapeutics monthly returns
Nektar Therapeutics has averaged 1.91% per month, positive in 48% of months. Month-by-month returns for Nektar Therapeutics (NKTR) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+1.9%
382 months
Best month
+139.3%
Jun 2025
Worst month
-49.3%
Mar 2023
Positive months
48%
of all months
Nektar Therapeutics monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -35.2% | |
| Sep 2026 | -15.2% | |
| Aug 2026 | +1.0% | |
| Jul 2026 | +1.2% | |
| Jun 2026 | +7.6% | |
| May 2026 | -23.7% | |
| Apr 2026 | +18.2% | |
| Mar 2026 | +4.3% | |
| Feb 2026 | +84.8% | |
| Jan 2026 | -11.7% | |
| Dec 2025 | -35.2% | |
| Nov 2025 | +0.4% | |
| Oct 2025 | +14.1% | |
| Sep 2025 | +90.6% | |
| Aug 2025 | +37.7% | |
| Jul 2025 | -16.1% | |
| Jun 2025 | +139.3% | |
| May 2025 | -10.0% | |
| Apr 2025 | +17.6% | |
| Mar 2025 | -19.0% | |
| Feb 2025 | +1.2% | |
| Jan 2025 | -10.8% | |
| Dec 2024 | -18.4% | |
| Nov 2024 | -4.2% | |
| Oct 2024 | -8.5% | |
| Sep 2024 | +1.6% | |
| Aug 2024 | -4.5% | |
| Jul 2024 | +8.1% | |
| Jun 2024 | -2.4% | |
| May 2024 | -13.0% | |
| Apr 2024 | +57.0% | |
| Mar 2024 | +31.0% | |
| Feb 2024 | +31.5% | |
| Jan 2024 | -3.6% | |
| Dec 2023 | +14.3% | |
| Nov 2023 | +4.3% | |
| Oct 2023 | -21.7% | |
| Sep 2023 | +0.0% | |
| Aug 2023 | +11.1% | |
| Jul 2023 | -6.9% | |
| Jun 2023 | +0.0% | |
| May 2023 | -22.7% | |
| Apr 2023 | +7.1% | |
| Mar 2023 | -49.3% | |
| Feb 2023 | -49.3% | |
| Jan 2023 | +20.4% | |
| Dec 2022 | -19.3% | |
| Nov 2022 | -25.5% | |
| Oct 2022 | +17.5% | |
| Sep 2022 | -18.8% | |
| Aug 2022 | -0.5% | |
| Jul 2022 | +4.2% | |
| Jun 2022 | +9.2% | |
| May 2022 | -15.7% | |
| Apr 2022 | -23.4% | |
| Mar 2022 | -47.4% | |
| Feb 2022 | -7.9% | |
| Jan 2022 | -17.7% | |
| Dec 2021 | +20.0% | |
| Nov 2021 | -25.7% | |
| Oct 2021 | -15.6% | |
| Sep 2021 | +16.0% | |
| Aug 2021 | -2.0% | |
| Jul 2021 | -8.0% | |
| Jun 2021 | -5.0% | |
| May 2021 | -7.9% | |
| Apr 2021 | -1.9% | |
| Mar 2021 | -11.9% | |
| Feb 2021 | +15.2% | |
| Jan 2021 | +15.9% | |
| Dec 2020 | +3.7% | |
| Nov 2020 | +3.5% | |
| Oct 2020 | -4.5% | |
| Sep 2020 | -14.2% | |
| Aug 2020 | -12.7% | |
| Jul 2020 | -4.3% | |
| Jun 2020 | +6.7% | |
| May 2020 | +13.0% | |
| Apr 2020 | +7.6% | |
| Mar 2020 | -14.2% | |
| Feb 2020 | +4.6% | |
| Jan 2020 | -7.9% | |
| Dec 2019 | +6.4% | |
| Nov 2019 | +18.4% | |
| Oct 2019 | -6.0% | |
| Sep 2019 | +3.7% | |
| Aug 2019 | -38.3% | |
| Jul 2019 | -20.0% | |
| Jun 2019 | +13.6% | |
| May 2019 | -2.2% | |
| Apr 2019 | -4.7% | |
| Mar 2019 | -17.1% | |
| Feb 2019 | -4.3% | |
| Jan 2019 | +28.8% | |
| Dec 2018 | -18.6% | |
| Nov 2018 | +4.4% | |
| Oct 2018 | -36.5% | |
| Sep 2018 | -8.3% | |
| Aug 2018 | +26.4% | |
| Jul 2018 | +7.7% | |
| Jun 2018 | -39.2% | |
| May 2018 | -4.1% | |
| Apr 2018 | -21.3% | |
| Mar 2018 | +22.8% | |
| Feb 2018 | +3.5% | |
| Jan 2018 | +40.0% | |
| Dec 2017 | +10.6% | |
| Nov 2017 | +124.1% | |
| Oct 2017 | +0.4% | |
| Sep 2017 | +14.1% | |
| Aug 2017 | -3.7% | |
| Jul 2017 | +11.7% | |
| Jun 2017 | -1.7% | |
| May 2017 | +4.8% | |
| Apr 2017 | -19.2% | |
| Mar 2017 | +79.4% | |
| Feb 2017 | +8.0% | |
| Jan 2017 | -1.3% | |
| Dec 2016 | -0.2% | |
| Nov 2016 | -0.9% |
Monthly total return (since Nov 2021)#
-100%-50%0%50%100%
Nov 2021-26%
Dec 2021+20%
Jan 2022-18%2022
Feb 2022-7.9%
Mar 2022-47%
Apr 2022-23%
May 2022-16%
Jun 2022+9.2%
Jul 2022+4.2%
Aug 2022-0.51%
Sep 2022-19%
Oct 2022+18%
Nov 2022-26%
Dec 2022-19%
Jan 2023+20%2023
Feb 2023-49%
Mar 2023-49%
Apr 2023+7.1%
May 2023-23%
Jun 20230%
Jul 2023-6.9%
Aug 2023+11%
Sep 20230%
Oct 2023-22%
Nov 2023+4.3%
Dec 2023+14%
Jan 2024-3.6%2024
Feb 2024+31%
Mar 2024+31%
Apr 2024+57%
May 2024-13%
Jun 2024-2.4%
Jul 2024+8.1%
Aug 2024-4.5%
Sep 2024+1.6%
Oct 2024-8.5%
Nov 2024-4.2%
Dec 2024-18%
Jan 2025-11%2025
Feb 2025+1.2%
Mar 2025-19%
Apr 2025+18%
May 2025-10%
Jun 2025+139%
Jul 2025-16%
Aug 2025+38%
Sep 2025+91%
Oct 2025+14%
Nov 2025+0.43%
Dec 2025-35%
Jan 2026-12%2026
Feb 2026+85%
Mar 2026+4.3%
Apr 2026+18%
May 2026-24%
Jun 2026+7.6%
Jul 2026+1.2%
Aug 2026+1.0%
Sep 2026-15%
Oct 2026-35%
Nektar Therapeutics returns by calendar month#
Every month of every year since 1995, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -35.23% — 31st of 32 Octobers since 1995 at the last close; the average October returned -2.0%.
| Month | −140%0+140% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +3.8% | +3.7% | 53% | +40.0% 2018 | -27.5% 2003 | |
| Feb | +3.0% | +1.6% | 53% | +84.8% 2026 | -49.3% 2023 | |
| Mar | -0.1% | -1.9% | 41% | +79.4% 2017 | -49.3% 2023 | |
| Apr | +1.7% | -1.7% | 47% | +57.0% 2024 | -30.5% 2008 | |
| May | -0.5% | -5.4% | 34% | +40.4% 2003 | -23.7% 2026 | |
| Jun | +3.7% | -1.4% | 44% | +139.3% 2025 | -39.2% 2018 | |
| Jul | -2.1% | -1.7% | 44% | +48.7% 2008 | -32.6% 2001 | |
| Aug | +3.0% | -1.2% | 47% | +51.6% 1995 | -38.3% 2019 | |
| Sep | +3.3% | -0.8% | 44% | +90.6% 2025 | -23.4% 2002 | |
| Oct | -2.0% | -6.0% | 39% | +54.0% 2008 | -36.5% 2018 | |
| Nov | +8.7% | +4.4% | 68% | +124.1% 2017 | -27.6% 2012 | |
| Dec | +1.5% | +1.9% | 61% | +39.0% 1999 | -35.2% 2025 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from NKTR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Nektar Therapeutics's average monthly return?
- Nektar Therapeutics (NKTR) has averaged about 1.91% per month, positive in roughly 48% of months. The best month was Jun 2025 (+139.3%) and the worst was Mar 2023 (-49.3%).
More on Nektar Therapeutics
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100